PHARMACEUTICAL SUPPLY CHAINS IN THE NEWS, FOR THE WRONG REASONS

Extreme caution required

THE HEPARIN TRAGEDY

In 2007/8, pharmaceutical supply chains became the subject of global debate among key stakeholders, but for the wrong reasons.

A tragic event occurred that shocked the world into realizing that pharmaceutical supply chains had the potential to kill and maim unsuspecting patients.

A blood thinning agent, heparin, had been adulterated […